Intellectual Property India Publishes Patent Application for 'Quinolinone Amide Compounds And Uses Thereof' Filed by Edgewise Therapeutics, Inc.

MUMBAI, India, Oct. 11 -- Intellectual Property India has published a patent application (202517090998 A) filed by Edgewise Therapeutics, Inc., Boulder, U.S.A., on Sept. 23, for 'quinolinone amide compounds and uses thereof.'

Inventor(s) include Hawryluk, Natalie Anne; Schlachter, Stephen Thomas; Koch, Kevin; Luzzio, Michael Joseph; Russell, Alan James; Evanchik, Marc Justin; Del Rio, Carlos Luis; and Hunt, Kevin.

The application for the patent was published on Oct. 10, under issue no. 41/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure generally relates to substituted quinolinone amide compounds or salts of Formula (I), (II-A), (IV), or (III) and pharmaceutical compositions thereof. The substituted quinolinone amide compounds or salts of Formula (I), (II-A), (IV), or (III) disclosed herein may be used to treat or prevent cardiac disease in an individual in need thereof."

The patent application was internationally filed on Mar. 26, 2024, under International application No.PCT/US2024/021528.

Disclaimer: Curated by HT Syndication.